New Strong Buy Stocks for November 21st

In this article:

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Aquestive Therapeutics, Inc. AQST: This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 72% over the last 60 days.

Aquestive Therapeutics, Inc. Price and Consensus

Aquestive Therapeutics, Inc. Price and Consensus
Aquestive Therapeutics, Inc. Price and Consensus

Aquestive Therapeutics, Inc. price-consensus-chart | Aquestive Therapeutics, Inc. Quote

Rubicon Technologies, Inc. RBT: This cloud-based waste and recycling solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 69% over the last 60 days.

Rubicon Technologies, Inc. Price and Consensus

Rubicon Technologies, Inc. Price and Consensus
Rubicon Technologies, Inc. Price and Consensus

Rubicon Technologies, Inc. price-consensus-chart | Rubicon Technologies, Inc. Quote

Harpoon Therapeutics, Inc. HARP: This immunotherapy company has seen the Zacks Consensus Estimate for its current year earnings increasing 64.2% over the last 60 days.

Harpoon Therapeutics, Inc. Price and Consensus

Harpoon Therapeutics, Inc. Price and Consensus
Harpoon Therapeutics, Inc. Price and Consensus

Harpoon Therapeutics, Inc. price-consensus-chart | Harpoon Therapeutics, Inc. Quote

Viad Corp VVI: This leisure travel and events experience company has seen the Zacks Consensus Estimate for its current year earnings increasing 140% over the last 60 days.

Viad Corp Price and Consensus

Viad Corp Price and Consensus
Viad Corp Price and Consensus

Viad Corp price-consensus-chart | Viad Corp Quote

Avalo Therapeutics, Inc. AVTX: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 90.3% over the last 60 days.

Avalo Therapeutics, Inc. Price and Consensus

Avalo Therapeutics, Inc. Price and Consensus
Avalo Therapeutics, Inc. Price and Consensus

Avalo Therapeutics, Inc. price-consensus-chart | Avalo Therapeutics, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Viad Corp (VVI) : Free Stock Analysis Report

Aquestive Therapeutics, Inc. (AQST) : Free Stock Analysis Report

Harpoon Therapeutics, Inc. (HARP) : Free Stock Analysis Report

Avalo Therapeutics, Inc. (AVTX) : Free Stock Analysis Report

Rubicon Technologies, Inc. (RBT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Advertisement